FibroGenesis

FibroGenesis is a regenerative medicine company dedicated to developing an innovative regenerative medicine drug solution for treating chronic diseases using fibroblasts. Currently, FibroGenesis holds 180 U.S. and international issued/pending patents across various clinical pathways, including degenerative disc disease, multiple sclerosis, Parkinson's disease, chronic traumatic encephalopathy, cancer, diabetes, liver failure, and heart failure. FibroGenesis represents the next generation of medical advancements in cell therapy.